1) BT-BAK
T淋巴毒细胞
1.
Objective To evaluate the intravesical instillation of mytomycin C(MMC) and BT-BAK for the prevention of bladder cancer recurrence.
目的 丝裂霉素C(MMC)联合肿瘤抗原诱导T淋巴毒细胞 (BT -BAK)膀胱灌注预防膀胱癌术后复发的疗效观察。
3) cytotoxic T lymphocyte
细胞毒性T淋巴细胞
1.
Influence of thermochemotherapy on the activity of cytotoxic T lymphocyte in oral maxillofacial cancer patients;
热化疗对口腔颌面癌患者细胞毒性T淋巴细胞活性的影响
2.
Study on the cytotoxic T lymphocytes of mice treated with leukemia vaccine;
白血病瘤苗对小鼠细胞毒性T淋巴细胞作用的研究
3.
Objective:To explore the in vitro immune response to tumor associated antigen MUC4-derived cytotoxic T lymphocyte(CTL) epitope-pulsed dendritic cell(DC).
目的:探讨肿瘤抗原MUC4 HLA-A *0201限制性细胞毒性T淋巴细胞(CTL)表位肽负载树突状细胞诱导CTL的体外免疫效应。
4) CTL
细胞毒性T淋巴细胞
1.
Potency of CTL killing tumor cells in vitro induced by dendritic cells loading with lung cancer antigen;
肺癌抗原负载的树突细胞体外诱导细胞毒性T淋巴细胞的杀瘤作用
2.
Objective:To investigate the effects of IFN-γ on the tumor specific CTLs induced by rhIL-18 in the in vitro cell co-culture system.
目的:应用rhIL-18在体外培养系统(Coculture system in vitro,CCs)中诱导肿瘤特异性细胞毒性T淋巴细胞(Cytotoxic TLymphocyte,CTL),探讨IFN-γ在rhIL-18诱导的肿瘤特异性CTL产生过程及杀伤效应中的作用。
3.
Objective To observe the effects of hyperbaric oxygen on the proliferation rate and total cytotoxicity T lymphocyte(CTL) activity of rat splenic lymphocytes.
目的观察大鼠体外脾淋巴细胞经不同压力—时程的高分压氧处理后淋巴细胞增殖及细胞毒性T淋巴细胞(CTL)杀伤能力的变化。
5) cytotoxic T lymphocytes
细胞毒性T淋巴细胞
1.
Objectve: To investigate whether the dendritic cells(DCs) loaded with the peptide derived from MAGE-A3 could induce specific cytotoxic T lymphocytes(CTLs) response in breast cancer patients in vitro.
目的研究MAGE-A3抗原肽负载对乳腺癌患者树突状细胞(DC)的功能的影响,探讨其是否可以在体外诱导特异性细胞毒性T淋巴细胞(CTL)应答。
6) CTL
细胞毒T淋巴细胞
1.
Cytokine assay,specific CTL activity,CTLp assay and the percentage of phenotypes in T cell were detected respectively by ELISA,LDH,ELISPOT and F.
为了研究重组CHO细胞乙肝表面抗原(CHO-rHBsAg)在小鼠中诱导T细胞免疫应答的能力,全面评价疫苗的免疫原性,以CHO-rHBsAg免疫BALB/c小鼠,常规制备小鼠脾脏淋巴细胞并在体外以抗原或特异多肽刺激;采用ELISA法测定抗原特异性T淋巴细胞分泌的细胞因子,乳酸脱氢酶法(LDH)测定抗原特异性细胞毒T淋巴细胞(CTL)活性,酶联斑点法(ELISPOT)测定CTL频数(CTLp),应用流式细胞仪分析T淋巴细胞亚群。
补充资料：淋巴细胞毒交叉配合试验
淋巴细胞毒交叉配合试验
lymphocyte cross matching
将含有细胞毒抗体的受者血清与供者的淋巴细胞加入补体后一起培养。受者血清中含有对抗供者淋巴细胞抗原HLA的抗体时，则两者结合后激活补体，损害供者淋巴细胞膜或引起细胞溶解。通过显微镜下观察死亡的淋巴细胞数量，可了解供受者之间的组织相容性。一般要求死亡细胞少于15%。若高于15%，移植后可能出现超急性排斥反应。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条